Stockscreener 앱 받기
58.40
6.43%
3.53
전일 마감가:
$54.87
열려 있는:
$54.4
하루 거래량:
27.28M
Relative Volume:
0.88
시가총액:
$12.71B
수익:
$1.78B
순이익/손실:
$164.40M
주가수익비율:
84.64
EPS:
0.69
순현금흐름:
$236.51M
1주 성능:
+1.00%
1개월 성능:
+28.78%
6개월 성능:
+75.06%
1년 성능:
+229.76%
1일 변동 폭
$54.11
$58.40
1주일 범위
$50.70
$58.94
52주 변동 폭
$16.05
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
명칭
Hims Hers Health Inc
전화
415-851-0195
주소
2269 CHESTNUT ST, SAN FRANCISCO
HIMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
58.40 | 12.40B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
143.50 | 62.55B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.74 | 46.27B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
8.82 | 38.87B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.34 | 21.06B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
432.66 | 19.24B | 2.99B | 1.21B | 1.13B | 25.06 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-23 | 다운그레이드 | Needham | Buy → Hold |
| 2025-06-04 | 재확인 | Needham | Buy |
| 2025-04-29 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-01-07 | 개시 | BTIG Research | Buy |
| 2024-12-17 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-08-22 | 개시 | Needham | Buy |
| 2024-08-09 | 다운그레이드 | Imperial Capital | Outperform → In-line |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-04-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-04-10 | 개시 | Canaccord Genuity | Buy |
| 2024-02-28 | 업그레이드 | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | Imperial Capital | In-line |
| 2023-07-28 | 개시 | TD Cowen | Outperform |
| 2023-04-11 | 개시 | Robert W. Baird | Neutral |
| 2023-02-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-08 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-07-15 | 개시 | SVB Leerink | Underperform |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-10 | 개시 | Deutsche Bank | Hold |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-11-11 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 개시 | BofA Securities | Neutral |
| 2021-05-20 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 개시 | Truist | Hold |
| 2021-03-09 | 개시 | Credit Suisse | Neutral |
| 2021-03-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 개시 | Citigroup | Neutral |
| 2021-02-12 | 개시 | Piper Sandler | Neutral |
| 2021-02-08 | 개시 | Tigress Financial | Buy |
모두보기
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Hims & Hers: Navigating GLP Controversy With AplombBut Risks Warrant Hold Rating (HIMS) - Seeking Alpha
Hims & Hers Health (NYSE:HIMS) Shares Up 5.7%Here's Why - MarketBeat
Best Medical Stocks To Add to Your WatchlistSeptember 26th - MarketBeat
Top Healthcare Stocks To Follow TodaySeptember 26th - MarketBeat
Hims & Hers: Growth Meets FDA Scrutiny And Tariff Risks (NYSE:HIMS) - Seeking Alpha
Hims & Hers Powers YieldMax's Latest Options-Based Income ETF - Benzinga
HIMS vs. DOCS: Which Digital Health Platform Is a Better Investment? - Yahoo Finance
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
1 Momentum Stock with Competitive Advantages and 2 We Find Risky - The Globe and Mail
Michael Chi Sells 2,100 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat
Healthcare Stocks To Follow TodaySeptember 25th - MarketBeat
2 Volatile Stocks Worth Investigating and 1 That Underwhelm - The Globe and Mail
Oluyemi Okupe Sells 23,584 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat
Promising Medical Stocks To Watch TodaySeptember 24th - MarketBeat
Healthcare Stocks To ResearchSeptember 24th - MarketBeat
Kuehn Law Encourages Investors of Hims & Hers Health, Inc. to Contact Law Firm - PR Newswire
Hims and Hers Weight Loss Success - wspa.com
I'm Downgrading Hims & Hers Stock - The Globe and Mail
Occidental Asset Management LLC Makes New Investment in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know - sharewise.com
Why the Hims & Hers Health Stock (HIMS) Rally is Only Just Getting Started - TipRanks
TTP Investments Inc. Takes Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Could FDA Scrutiny of Weight Loss Drugs Reshape Hims & Hers Health's (HIMS) Category Expansion Strategy? - simplywall.st
Medical Stocks To Follow TodaySeptember 23rd - MarketBeat
HIMS Stock Just Got Rocked (Again) By the FDA. This Analyst Still Thinks Hims & Hers Can Surge 50%. - Barchart.com
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today - TradingView
Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy - Investing.com
YieldMax® Introduces Option Income Strategy ETF on Hims & Hers Health Inc. (HIMS) - The Manila Times
Abacus FCF Advisors LLC Cuts Stock Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health Expands Information Dissemination Strategy - TipRanks
Medical Stocks To Add to Your WatchlistSeptember 22nd - MarketBeat
The charts on this telehealth stock point to strong gains ahead, according to Katie Stockton - CNBC
Voya Investment Management LLC Sells 127,512 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Expands Care Ecosystem via Global and Digital Innovation - Yahoo Finance
4 Tips for Better Sleep From a Hims & Hers Founder - Inc.com
Hims & Hers Health (NYSE:HIMS) Insider Sells $694,324.50 in Stock - MarketBeat
Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy - sharewise.com
Online pharmacies are still selling cheap copycat Ozempic and other weight loss drugs, despite new FDA rules - Business Insider
Insider Selling: Hims & Hers Health (NYSE:HIMS) CEO Sells 128,127 Shares of Stock - MarketBeat
Aug PostEarnings: Can Hims Hers Health Inc maintain sales growth2025 Key Lessons & Stepwise Entry/Exit Trade Alerts - khodrobank.com
Insider Selling: Hims & Hers Health (NYSE:HIMS) Insider Sells 2,637 Shares of Stock - MarketBeat
Hims & Hers Health (NYSE:HIMS) CEO Sells $3,292,612.70 in Stock - MarketBeat
Hims & Hers Health (NYSE:HIMS) Insider Patrick Harrison Carroll Sells 10,021 Shares - MarketBeat
Irene Becklund Sells 8,410 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat
Strs Ohio Buys New Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health, Inc. $HIMS Stock Holdings Increased by Fiduciary Alliance LLC - MarketBeat
Rep. Lisa C. McClain Purchases Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Insider Sell: Soleil Boughton Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus
Belpointe Asset Management LLC Has $225,000 Stake in Hims & Hers Health, Inc. $HIMS - MarketBeat
Best Healthcare Stocks To Follow NowSeptember 19th - MarketBeat
Hims & Hers Health (NYSE:HIMS) Trading 9.3% HigherStill a Buy? - MarketBeat
Hims Hers Health Inc (HIMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
자본화:
|
볼륨(24시간):